Stanrose Mafatlal Investments & Finance Intrinsic Value
Stanrose Mafatlal Investments & Finance (STANROS) median intrinsic value is ₹25.80 from 3 valuation models (range ₹19–₹84), vs current price ₹64.50 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit STANROS share price.
STANROS Valuation Methods Summary — DCF, Graham Number & P/E
Stanrose Mafatlal Investments & Finance intrinsic value across 3 models vs current price ₹64.50 — upside/downside and value range per method. Browse STANROS quarterly financials for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹84.00 | ₹75.60 - ₹92.40 | +30.2% | Book Value/Share: ₹105.00, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹19.35 | ₹17.42 - ₹21.29 | -70.0% | Revenue/Share: ₹10.00, P/S: 1.0x |
| Simple DCF (5Y) | dcf | ₹25.80 | ₹20.64 - ₹30.96 | -60.0% | CF Growth: 5.0%, Discount: 15% |
STANROS Intrinsic Value vs Market Price — All Valuation Models
Stanrose Mafatlal Investments & Finance fair value range ₹19–₹84 vs current market price ₹64.50 across 3 valuation models. Compare with STANROS fair value to assess whether the stock is under or overvalued.
STANROS Intrinsic Value Analysis — Undervalued or Overvalued?
Stanrose Mafatlal Investments & Finance median intrinsic value ₹25.80, current price ₹64.50 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of STANROS?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Stanrose Mafatlal Investments & Finance (STANROS) is ₹25.80 (median value). With the current market price of ₹64.50, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹19.35 to ₹84.00, indicating ₹19.35 - ₹84.00.
Is STANROS undervalued or overvalued?
Based on our multi-method analysis, Stanrose Mafatlal Investments & Finance (STANROS) appears to be trading above calculated value by approximately 60.0%.
STANROS Financial Health — Key Ratios vs Industry Benchmarks
Stanrose Mafatlal Investments & Finance financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.05 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -9.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -132.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.09x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
STANROS Cash Flow Quality — Operating & Free Cash Flow
Stanrose Mafatlal Investments & Finance operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |